跳至主要内容
临床试验/NCT00093665
NCT00093665Unknown2 期

A Phase II Study Of Alternating Chemoradiotherapy For Nasopharyngeal Cancer Using Cisplatin And 5-Fluorouracil

Aichi Cancer Center14 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2003年11月最近更新:
适应症
相关药物

试验速览

阶段
2 期
入组人数
90
试验地点
14
主要终点
Progression-free survival at 3 years

研究概览

简要总结

RATIONALE: Drugs used in chemotherapy, such as fluorouracil and cisplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining fluorouracil and cisplatin with radiation therapy may kill more tumor cells.

PURPOSE: This phase II trial is studying how well giving fluorouracil and cisplatin together with radiation therapy works in treating patients with stage II, stage III, or stage IV nasopharyngeal cancer.

详细描述

OBJECTIVES:

Primary

  • Determine progression-free survival of patients with previously untreated stage IIB-IVB nasopharyngeal cancer treated with fluorouracil, cisplatin, and radiotherapy.

Secondary

  • Determine overall survival and response rate in patients treated with this regimen.
  • Determine compliance to this regimen in these patients.
  • Determine the toxicity of this regimen in these patients.

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Progression-free survival at 3 years

次要结局

  • Overall survival
  • Response rate
  • Treatment completion rate
  • Incidence of adverse effects

研究者

申办方类型
Other

研究点 (14)

Loading locations...

相似试验